Prospects for a vaccine against the hepatitis C virus
Top Cited Papers
- 17 August 2005
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 436 (7053) , 961-966
- https://doi.org/10.1038/nature04081
Abstract
The recent discovery of natural immunity to the hepatitis C virus and vaccine efficacy in the chimpanzee challenge model has allowed optimism about the development of at least a partly effective vaccine against this heterogeneous pathogen that is responsible for much of the chronic liver disease around the world. The immune systems of some infected individuals can spontaneously clear the virus, whereas other people need treatment with antivirals that work partly by stimulating humoral and cellular immune responses. Therefore, therapeutic vaccine strategies are also being pursued to improve treatment outcome.Keywords
This publication has 72 references indexed in Scilit:
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Deoxycytidyl-Deoxyguanosine Oligonucleotide Classes A, B, and C Induce Distinct Cytokine Gene Expression Patterns in Rhesus Monkey Peripheral Blood Mononuclear Cells and Distinct Alpha Interferon Responses in TLR9-Expressing Rhesus Monkey Plasmacytoid Dendritic CellsClinical and Vaccine Immunology, 2005
- Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent MannerJournal of Virology, 2004
- HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus InfectionScience, 2004
- The evolving treatment of chronic hepatitis C: where we stand a decade out.Cleveland Clinic Journal of Medicine, 2004
- HCV Persistence and Immune Evasion in the Absence of Memory T Cell HelpScience, 2003
- The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral QuasispeciesScience, 2000
- Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis CHepatology, 1998
- RELIABILITY OF CHIMPANZEE MODEL FOR NON-A, NON-B HEPATITISThe Lancet, 1985